VYNE Therapeutics Inc (VYNE)
2.48
+0.01
(+0.40%)
USD |
NASDAQ |
Apr 26, 16:00
2.48
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Total Assets (Quarterly): 97.68M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 97.68M |
| September 30, 2023 | 19.27M |
| June 30, 2023 | 24.96M |
| March 31, 2023 | 35.26M |
| December 31, 2022 | 40.76M |
| September 30, 2022 | 46.91M |
| June 30, 2022 | 55.19M |
| March 31, 2022 | 64.32M |
| December 31, 2021 | 67.05M |
| September 30, 2021 | 81.32M |
| June 30, 2021 | 133.98M |
| March 31, 2021 | 149.17M |
| December 31, 2020 | 93.74M |
| September 30, 2020 | 107.68M |
| Date | Value |
|---|---|
| June 30, 2020 | 130.84M |
| March 31, 2020 | 160.53M |
| December 31, 2019 | 79.17M |
| September 30, 2019 | 96.58M |
| June 30, 2019 | 114.38M |
| March 31, 2019 | 126.26M |
| December 31, 2018 | 139.93M |
| September 30, 2018 | 154.96M |
| June 30, 2018 | 166.92M |
| March 31, 2018 | 180.48M |
| December 31, 2017 | 66.87M |
| September 30, 2017 | 75.80M |
| December 31, 2016 | 42.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.27M
Minimum
Sep 2023
160.53M
Maximum
Mar 2020
84.15M
Average
81.32M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Viking Therapeutics Inc | 967.52M |
| AN2 Therapeutics Inc | 138.74M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.95M |
| Shareholders Equity (Quarterly) | 88.74M |
| Current Ratio | 12.73 |